Ependymomas: MIB-1 proliferation index and survival

Journal of Neuro-Oncology

Volumn 40, Issue 1, 1998, Pages 51-57

  Ritter, Ann M ^a   Hess, Kenneth R ^b   McLendon, Roger E ^c   Langford, Lauren A ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Brain tumor; Ependymoma; Ki 67; MIB 1; Proliferation index; Survival

Indexed keywords

KI 67 ANTIGEN;

ADOLESCENT; ADULT; ANAPLASTIC CARCINOMA; ARTICLE; BRAIN BIOPSY; BRAIN SURGERY; CELL PROLIFERATION; CELL SURVIVAL; CHILD; CLINICAL ARTICLE; EPENDYMOMA; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; MITOSIS; MITOSIS INDEX; NECROSIS; OUTCOMES RESEARCH; PROGNOSIS; SURVIVAL;

ADOLESCENT; ADULT; ANTIGENS, NUCLEAR; BIOLOGICAL MARKERS; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; EPENDYMOMA; FEMALE; HUMANS; INFANT; KI-67 ANTIGEN; MALE; MIDDLE AGED; NUCLEAR PROTEINS; PROGNOSIS; SPINAL CORD NEOPLASMS; SURVIVAL ANALYSIS;

EID: 0031789904     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006082622699     Document Type: Article

References (36)

1. Áfra D, Müller W, Slowik F, Wilcke O, Budka H, Túróczy L: Supratentorial lobar ependymomas: reports on the grading and survival periods in 80 cases, including 46 recurrences. Acta Neurochir (Wien) 69: 243-251, 1983
2. Figarella-Branger D, Gambarelli D, Dollo C, Devictor B, Perez-Castillo AM, Genitori L, Lena G, Choux M, Pellissier JF: Infratentorial ependymomas of childhood. Correlation between histological features, immunohistological phenotype, silver nucleolar organizer region staining values and post-operative survival in 16 cases. Acta Neuropathol (Berl) 82: 208-216, 1991
3. Healey EA, Barnes PD, Kupsky WJ, Scott RM, Sallan SE, Black PM, Tarbell NJ: The prognostic significance of post-operative residual tumor in ependymoma. Neurosurgery 28: 666-672, 1991
4. Liu H, Boggs K, Kidd J: Ependymomas of childhood. 1. Histological survey and clinicopathological correlation. Child's Brain 2: 92-110, 1976
5. Nazar GB, Hoffman HJ, Becker LE, Jenkin D, Humphreys RP, Hendrick EB: Infratentorial ependymomas in childhood: prognostic factors and treatment. J Neurosurg 72: 408-417, 1990
6. Kleihues P, Burger PC, Scheithauer BW: Histologic typing of tumors of the central nervous system. Springer-Verlag, Berlin. 1993
7. Rorke LB: Relationship of morphology of ependymomas in children to prognosis. Prog Exp Tumor Res 30: 170-174.
8. Rorke LB, Gilles FH, David RL, Becker LE: Revision of the World Health Organization classification ot brain tumors for childhood brain tumors. Cancer 56: 1869-1886, 1985
9. Zülch K: Brain tumors: Their biology and pathology: Berlin, Springer-Verlag, 1986
10. Barone BM, Elvidge AR: Ependymomas: a clinical study. J Neurosurg 33: 428-438, 1970
11. Ilgren EB, Stiller CA, Hughes JT, Silberman D, Steckel N, Kaye A: Ependymomas: a clinical and pathologic study. Part II. Survival features. Clin Neuropathol 3: 122-127, 1984
12. Rawlings CE, Giangaspero F, Burger PC, Bullard DE: Ependymomas: a clinicopathologic study. Surg Neurol 29: 271-281, 1988
13. Reyes-Mugica M, Chou PM, Myint MM, Ridaura-Sanz C, Gonzalez-Crussi F, Tomita T: Ependymomas in children: histologic and DNA- flow cytometric study. Pediatr Pathology 14: 453-466, 1994
14. Ross GW, Rubinstein LJ: Lack of bistopathological correlation of malignant ependymomas with postoperative survival. J Neurosurg 70: 31-36, 1989
15. Schiffer D, Chio A, Giordana MT, Migheli A, Palma L, Pollo B, Soffietti R, Tribolo A: Histologic prognostic factors in ependymomas. Childs Nerv Syst 7: 177-182, 1991
16. Shuman RM, Alvord EC Jr, Leech RW: The biology of childhood ependymomas. Arch Neurol 32: 731-739, 1975
17. Coldwein JW, Glauser TA, Packer RJ, Finlay JL, Sutton LN, Curran WJ, Laehy JM, Rorke LB, Schut L, D'Angio GJ: Recurrent intracranial ependymomas in children. Survival, patterns of failure, and prognostic factors. Cancer 66: 557-563, 1990
18. Mørk SJ, Løken AC: Ependymoma. A follow-up study of 101 cases. Cancer 40: 907-915, 1977
19. Chiu J, Woo S, Ater J, Connelly JM, Bruner JM, Maor MH, van Eys J, Oswald MJ, Shallenberger R: Intracranial ependymoma in children: analysis of prognostic factors. Neurooncology 13: 283-290, 1992
20. Ferrante L, Mastronardi L, Schettini G, Lunardi P, Fortuna A: Fourth ventricle ependymomas. Acta Neurochir (Wien) 131: 67-74, 1994
21. Lyons MK, Kelly PJ: Posterior fossa ependymomas: report of 30 cases and review of the literature. Neurosurgery 28: 659-665, 1991
22. Vigliani M, Schiffer D: Prognosis and treatment of 'anaplastic' ependymoma. Critical Review of Neurosurgery 2: 34-43, 1992
23. Asai A, Hoshino T, Edwards M, Davis RL: Predicting the recurrence of ependymomas from the bromodeoxyuridine labeling index. Childs Nerv Syst 8: 273-278, 1992
24. Shibuya M, Ito S, Miwa T, Davis RL, Wilson CB, Hoshino T: Proliferative potential of brain tumors. Analysis with Ki 67 and anti-DNA polymerase alpha monoclonal antibodies, bromodeoxyuridine labeling and nucleolar organizer region counts. Cancer 71:199-206, 1993
25. Karamitopoulou E, Perentes E, Diamantis I, Maraziotis T: Ki-67 immunoreactivity in human central nervous system tumors: a study of MIB-1 monoclonal antibody on archival material. Acta Neuropathol (Berl) 87: 47-54, 1994
26. Nagashima T, Hoshino T, Cho KG, Edwards MS, Hudgins RJ, Davis RL: The proliferative potential of human ependymomas measured by in situ bromodeoxyuridine labeling. Cancer 61: 2433-2438, 1988
27. Patsouris E, Stocker U, Kallmeyer V, Keiditsch E, Mehraein P, Stavrou D: Relationship between Ki-67 positive cells, growth rate, and histological type of human intracranial tumors, Anticancer Res 8: 537-544, 1988
28. Rezai AR, Woo HH, Lee M, Cohen H, Zagzag D, Epstein FJ: Disseminated ependymomas of the central nervous sytem. J Neurosurg 85: 618-624, 1996
29. Brown DC, Gatter KC: Monoclonal antibody Ki-67: its use in histopathology. Histopathology 17: 489-503, 1990
30. Cattoretti G, Becker M, Key G, Duchrow M, Schluter C, Galle J, Gerdes J: Monoclonal antibodies against recombinant part of the Ki-67 antigen (MIB-1 and MIB-3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 168: 356-363, 1992
31. Shi S, Keu ME, Kaira KL: Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39: 741-748, 1991
32. Tomita T, McLone D, Das L, Brand WN: Benign ependymomas of the posterior fossa in childhood. Pediatr Neuroscience 14: 277, 1988
33. Salazar O, Castro-Vita H, VanHoutte P, Rubin P, Aygun C: Improved survival in cases of intracranial ependymoma after radiation therapy: late report and recommendations. J Neurosurg 59: 652-659, 1984
34. Ernestus RI, Wilcke O, Schröder R: Supratentorial ependymomas in childhood: clinicopathological findings and prognosis. Acta Neurochir (Wien) 111: 96-102, 1991
35. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133: 1710-1715, 1984
36. Gerdes J, Li L, Schleuter C, Duchrow M, Wohlenberg C, Gerlach C, Stahmer I, Kloth S, Brandt E, Flad HD: Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 138: 867-873, 1991